SZSean Zhu

Sean Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sean Zhu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Ananya Beruar

    Division of Radiation Oncology, Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Cross Cancer Institute, 11560 University Avenue NW, Edmonton, AB T6G 1Z2, Canada

    1 shared publication
  • Ericka Wiebe

    Division of Radiation Oncology, Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Cross Cancer Institute, 11560 University Avenue NW, Edmonton, AB T6G 1Z2, Canada

    1 shared publication
  • Haley D. Frerichs

    Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada

    1 shared publication
  • Jasmine Gill

    Faculty of Medicine and Dentistry, University of Alberta, Walter C. Mackenzie Health Sciences Centre, 8440 112 Street NW, Edmonton, AB T6G 2R7, Canada

    1 shared publication
  • Sophia Pin

    Cross Cancer Institute, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada

    1 shared publication
  • Sunita Ghosh

    Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada

    1 shared publication

Latest Publications

  • Open Access

    Endometrial Cancer Recurrence Risk Following Robotic Hysterectomy

    by Sean Zhu, Ericka Wiebe, Haley Frerichs, Sunita Ghosh, Jasmine Gill, Zainab Al Habsi, Ananya Beruar, Sophia Pin

    Background: Minimally invasive surgery is widely used in endometrial cancer management, but recurrence remains a concern. Methods: A retrospective review of 1201 patients treated from 2012 to 2019 with robotic laparoscopy was conducted. Recurrence-free survival and hazard ratios were calculated using multivariate Cox models. Results: Of 1278 patients, 155 cases of recurrent disease were identified. Age (HR 1.01, p = 0.045), LVSI (HR 3.54, p < 0.001), stage and high-grade histology (HR 3.39, p < 0.001) were associated with increased risk of recurrence. Hazard ratios for stages IB, II and III/IV were 1.92 (p = 0.007), 2.67 (p = 0.001), and 3.23 (p < 0.001) respectively. The use of a uterine manipulator was an independent risk factor on multivariate analysis (HR 2.12, p < 0.001). Adjuvant chemotherapy (HR 0.67, p = 0.239) and radiotherapy (HR 0.64, p = 0.056) trends favored reduced risk but were not significant. Chemoradiotherapy was found to have a reduction in recurrence with a HR 0.44 (p = 0.002). Conclusions: Traditional prognostic factors remain important for patients with endometrial cancer having undergone robotic laparoscopic hysterectomy. Uterine manipulator use should be carefully reconsidered in endometrial cancer surgery.